Pre-made Imaprelimab benchmark antibody ( Whole mAb, anti-MCAM therapeutic antibody, Anti-CD146/HEMCAM/METCAM8/MelCAM Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-266

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-266 Category Tag

Product Details

Pre-Made Imaprelimab biosimilar, Whole mAb, Anti-MCAM Antibody: Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Imaprelimab biosimilar, Whole mAb, Anti-MCAM Antibody: Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic antibody

INN Name

Imaprelimab

Target

MCAM

Format

Whole mAb

Derivation

Humanized

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Phase-I

Est. Status

Discontinued

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2017

Companies

Neotope Biosciences,Onclave Therapeutics,Prothena,Prothena Corporation

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

Cancer,Inflammation,Psoriasis

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

MCAM

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide